Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2017

15.04.2017 | Retinal Disorders

Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique

verfasst von: Efrat Fleissig, Adiel Barak, Michaela Goldstein, Anat Loewenstein, Shulamit Schwartz

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate the efficacy and visual outcome of massive submacular hemorrhage (SMH) displacement with a planned two-step pars plana vitrectomy (PPV) using tissue plasminogen activator (tPA) and perfluorocarbon liquid (PFCL) tamponade.

Methods

A retrospective case series of patients with age related macular degeneration and SMH was used. All patients underwent a 23G PPV, subretinal tPA injection and a medium term PFCL tamponade. A second stage PPV for PFCL removal was performed 7-17 days later. The main outcome was the change in macular and sub-RPE thickness after 6 months. Secondary outcomes were visual acuity and complications.

Results

Seven patients (seven eyes) with mean age of 79.85 years were enrolled. The average SMH size was 17.5 disc area (range 4.5-33) with mean symptoms of a duration of 9.5 days (range: 2-21). SMH was successfully displaced in six eyes. Mean macular and sub-RPE thickness decreased from 1505μ to 711.3μ and 900 μ to 457μ, respectively. Visual acuity (VA) remained stable in five eyes. Complications included corneal edema and transient intraocular pressure elevation in three patients.

Conclusions

SMH displacement using subretinal tPA injection and medium term PFCL tamponade is an effective alternative treatment option. In our experience, it can be safely performed, avoiding complications commonly attributed to other techniques.
Literatur
1.
Zurück zum Zitat Shultz RW, Bakri SJ (2011) Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration. Semin Ophthalmol 26:361–371CrossRefPubMed Shultz RW, Bakri SJ (2011) Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration. Semin Ophthalmol 26:361–371CrossRefPubMed
2.
Zurück zum Zitat Berrocal MH, Lewis ML, Flynn HW (1996) Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 122:486–493CrossRefPubMed Berrocal MH, Lewis ML, Flynn HW (1996) Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 122:486–493CrossRefPubMed
3.
Zurück zum Zitat Avery RL, Fekrat S, Hawkins BS, Bressler NM (1996) Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 16:183–189CrossRefPubMed Avery RL, Fekrat S, Hawkins BS, Bressler NM (1996) Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 16:183–189CrossRefPubMed
4.
Zurück zum Zitat Poliner LS, Olk RJ, Burgess D, Gordon ME (1986) Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 93:543–551CrossRefPubMed Poliner LS, Olk RJ, Burgess D, Gordon ME (1986) Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 93:543–551CrossRefPubMed
5.
Zurück zum Zitat Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431CrossRefPubMed Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431CrossRefPubMed
6.
Zurück zum Zitat Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report 1. Arch Ophthalmol 117:1329–1345CrossRef Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report 1. Arch Ophthalmol 117:1329–1345CrossRef
7.
Zurück zum Zitat Bressler NM, Bressler SB, Childs AL, Haller JA et al (2004) Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 111:1993–2006CrossRefPubMed Bressler NM, Bressler SB, Childs AL, Haller JA et al (2004) Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 111:1993–2006CrossRefPubMed
8.
Zurück zum Zitat Childs AL, Bressler NM, Bass EB, Hawkins BS et al (2004) Submacular Surgery Trials (SST) Research Group. surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. Ophthalmology 111:2007–2014CrossRefPubMed Childs AL, Bressler NM, Bass EB, Hawkins BS et al (2004) Submacular Surgery Trials (SST) Research Group. surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. Ophthalmology 111:2007–2014CrossRefPubMed
9.
Zurück zum Zitat Lewis H, Resnick SC, Flannery JG, Straatsma BR (1991) Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 111:197–204CrossRefPubMed Lewis H, Resnick SC, Flannery JG, Straatsma BR (1991) Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 111:197–204CrossRefPubMed
10.
Zurück zum Zitat Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118:559–568CrossRefPubMed Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118:559–568CrossRefPubMed
11.
Zurück zum Zitat Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11CrossRefPubMed Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11CrossRefPubMed
12.
Zurück zum Zitat Fang IM, Lin YC, Yang CH, Yang CM, Chen MS (2009) Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Eye (Lond) 23:397–406CrossRef Fang IM, Lin YC, Yang CH, Yang CM, Chen MS (2009) Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Eye (Lond) 23:397–406CrossRef
13.
Zurück zum Zitat Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27:321–328CrossRefPubMed Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27:321–328CrossRefPubMed
14.
Zurück zum Zitat Cho HJ, Koh KM, Kim JH, Kim HS, Han JI, Lew YJ, Lee TG, Kim JW (2015) Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration. Retina 35:205–212CrossRefPubMed Cho HJ, Koh KM, Kim JH, Kim HS, Han JI, Lew YJ, Lee TG, Kim JW (2015) Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration. Retina 35:205–212CrossRefPubMed
15.
Zurück zum Zitat Shienbaum G, Garcia Filho CA, Flynn HW, Nunes RP, Smiddy WE, Rosenfeld PJ (2013) Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol 155:1009–1013CrossRefPubMed Shienbaum G, Garcia Filho CA, Flynn HW, Nunes RP, Smiddy WE, Rosenfeld PJ (2013) Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol 155:1009–1013CrossRefPubMed
16.
Zurück zum Zitat Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM (2010) Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina 30:1171–1176CrossRefPubMed Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM (2010) Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina 30:1171–1176CrossRefPubMed
17.
Zurück zum Zitat Moisseiev E, Ben Ami T, Barak A (2014) Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD. Eur J Ophthalmol 24:925–931CrossRefPubMed Moisseiev E, Ben Ami T, Barak A (2014) Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD. Eur J Ophthalmol 24:925–931CrossRefPubMed
18.
Zurück zum Zitat Sandhu SS, Manvikar S, Steel DH (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642PubMedPubMedCentral Sandhu SS, Manvikar S, Steel DH (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642PubMedPubMedCentral
19.
Zurück zum Zitat Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC (2014) Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 157:1250–1257CrossRefPubMed Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC (2014) Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 157:1250–1257CrossRefPubMed
20.
Zurück zum Zitat Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC (2004) Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 111:1201–1208CrossRefPubMed Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC (2004) Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 111:1201–1208CrossRefPubMed
21.
Zurück zum Zitat Drury B, Bourke RD (2011) Short term intraocular tamponade with perfluorocarbon heavy liquid. Br J Ophthalmol 95:694–698CrossRefPubMed Drury B, Bourke RD (2011) Short term intraocular tamponade with perfluorocarbon heavy liquid. Br J Ophthalmol 95:694–698CrossRefPubMed
22.
Zurück zum Zitat Sirimaharaj M, Balachandran C, Chan WC, Hunyor AP, Chang AA, Gregory-Roberts J, Hunyor AB, Playfair TJ (2005) Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. Br J Ophthalmol 89:1176–1179CrossRefPubMedPubMedCentral Sirimaharaj M, Balachandran C, Chan WC, Hunyor AP, Chang AA, Gregory-Roberts J, Hunyor AB, Playfair TJ (2005) Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. Br J Ophthalmol 89:1176–1179CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Rofail M, Lee LR (2005) Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina 25:897–901CrossRefPubMed Rofail M, Lee LR (2005) Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina 25:897–901CrossRefPubMed
24.
Zurück zum Zitat Imaizumi A, Kusaka S, Noguchi H, Shimomura Y, Sawaguchi S (2014) Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment. Am J Ophthalmol 157:384–389CrossRefPubMed Imaizumi A, Kusaka S, Noguchi H, Shimomura Y, Sawaguchi S (2014) Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment. Am J Ophthalmol 157:384–389CrossRefPubMed
25.
Zurück zum Zitat Steel DH, Sandhu SS (2011) Submacular haemorrhages associated with neovascular age-related macular degeneration. Br J Ophthalmol 95:1051–1057CrossRefPubMed Steel DH, Sandhu SS (2011) Submacular haemorrhages associated with neovascular age-related macular degeneration. Br J Ophthalmol 95:1051–1057CrossRefPubMed
26.
Zurück zum Zitat Bennett SR, Folk JC, Blodi CF, Klugman M (1990) Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 109:33–37CrossRefPubMed Bennett SR, Folk JC, Blodi CF, Klugman M (1990) Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 109:33–37CrossRefPubMed
27.
Zurück zum Zitat Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y (2009) Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina 29:677–681CrossRefPubMed Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y (2009) Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina 29:677–681CrossRefPubMed
28.
Zurück zum Zitat Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374CrossRefPubMed Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374CrossRefPubMed
29.
Zurück zum Zitat Mackiewicz J, Maaijwee K, Lüke C, Kociok N, Hiebl W, Meinert H, Joussen AM (2007) Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefes Arch Clin Exp Ophthalmol 245:665–675CrossRefPubMed Mackiewicz J, Maaijwee K, Lüke C, Kociok N, Hiebl W, Meinert H, Joussen AM (2007) Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefes Arch Clin Exp Ophthalmol 245:665–675CrossRefPubMed
30.
Zurück zum Zitat Figueroa MS, Casas DR (2014) Inflammation induced by perfluorocarbon liquid: intra- and postoperative use. Biomed Res Int. Article ID 907816 Figueroa MS, Casas DR (2014) Inflammation induced by perfluorocarbon liquid: intra- and postoperative use. Biomed Res Int. Article ID 907816
31.
Zurück zum Zitat Hattenbach LO, Klais C, Koch FH, Gümbel HO (2001) Intravitreous injection of tissue plaminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 108:1485–1492CrossRefPubMed Hattenbach LO, Klais C, Koch FH, Gümbel HO (2001) Intravitreous injection of tissue plaminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 108:1485–1492CrossRefPubMed
32.
Zurück zum Zitat Schulze SD, Hesse L (2002) Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variable for visual outcome. Graefes Arch Clin Exp Ophthalmol 240:717–720CrossRefPubMed Schulze SD, Hesse L (2002) Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variable for visual outcome. Graefes Arch Clin Exp Ophthalmol 240:717–720CrossRefPubMed
33.
Zurück zum Zitat Sigler EJ, Randolph JC, Charles S (2014) Foreign body response within postoperative perfluoro-n-octane for retinal detachment repair. Retina 34:237–246CrossRefPubMed Sigler EJ, Randolph JC, Charles S (2014) Foreign body response within postoperative perfluoro-n-octane for retinal detachment repair. Retina 34:237–246CrossRefPubMed
34.
Zurück zum Zitat Stolba U, Krepler K, Velikay M, Binder S (1999) Anterior segment changes in rabbits after experimental aqueous replacement with various amounts of different perfluorocarbon liquids. Graefes Arch Clin Exp Ophthalmol 237:501–507CrossRefPubMed Stolba U, Krepler K, Velikay M, Binder S (1999) Anterior segment changes in rabbits after experimental aqueous replacement with various amounts of different perfluorocarbon liquids. Graefes Arch Clin Exp Ophthalmol 237:501–507CrossRefPubMed
35.
Zurück zum Zitat Cauchi P, Azuara-Blanco A, McKenzie J (2005) Corneal toxicity and inflammation secondary to retained perfluorodecalin. Am J Ophthalmol 140:322–323CrossRefPubMed Cauchi P, Azuara-Blanco A, McKenzie J (2005) Corneal toxicity and inflammation secondary to retained perfluorodecalin. Am J Ophthalmol 140:322–323CrossRefPubMed
36.
Zurück zum Zitat Wilbanks GA, Apel AJ, Jolly SS, Devenyi RG, Rootman DS (1996) Perfluorodecalin corneal toxicity: five case reports. Cornea 15:329–334CrossRefPubMed Wilbanks GA, Apel AJ, Jolly SS, Devenyi RG, Rootman DS (1996) Perfluorodecalin corneal toxicity: five case reports. Cornea 15:329–334CrossRefPubMed
37.
Zurück zum Zitat Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, Grand MG (1995) Surgical management of submacular hemorrhage. a series of 47 consecutive cases. Arch Ophthalmol 113:62–69CrossRefPubMed Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, Grand MG (1995) Surgical management of submacular hemorrhage. a series of 47 consecutive cases. Arch Ophthalmol 113:62–69CrossRefPubMed
Metadaten
Titel
Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique
verfasst von
Efrat Fleissig
Adiel Barak
Michaela Goldstein
Anat Loewenstein
Shulamit Schwartz
Publikationsdatum
15.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3648-3

Weitere Artikel der Ausgabe 7/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.